vs
Cytek Biosciences, Inc.（CTKB）与INTEST CORP（INTT）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是INTEST CORP的1.9倍（$62.1M vs $32.8M），INTEST CORP净利率更高（3.8% vs -70.9%，领先74.7%），Cytek Biosciences, Inc.同比增速更快（8.1% vs -10.3%），INTEST CORP自由现金流更多（$-1.6M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 4.9%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
INTEST CORP是面向全球半导体产业的专业测试设备供应商，主营研发、生产及销售热管理系统、测试接口硬件、晶圆处理工具等产品，客户覆盖晶圆制造厂、芯片设计企业及汽车、工业电子等下游领域。
CTKB vs INTT — 直观对比
营收规模更大
CTKB
是对方的1.9倍
$32.8M
营收增速更快
CTKB
高出18.4%
-10.3%
净利率更高
INTT
高出74.7%
-70.9%
自由现金流更多
INTT
多$216.0K
$-1.8M
两年增速更快
CTKB
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $32.8M |
| 净利润 | $-44.1M | $1.2M |
| 毛利率 | 52.9% | 45.4% |
| 营业利润率 | -9.0% | 3.9% |
| 净利率 | -70.9% | 3.8% |
| 营收同比 | 8.1% | -10.3% |
| 净利润同比 | -557.1% | -17.4% |
| 每股收益（稀释后） | — | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBINTT
| Q4 25 | $62.1M | $32.8M | ||
| Q3 25 | $52.3M | $26.2M | ||
| Q2 25 | $45.6M | $28.1M | ||
| Q1 25 | $41.5M | $26.6M | ||
| Q4 24 | $57.5M | $36.6M | ||
| Q3 24 | $51.5M | $30.3M | ||
| Q2 24 | $46.6M | $34.0M | ||
| Q1 24 | $44.9M | $29.8M |
净利润CTKBINTT
| Q4 25 | $-44.1M | $1.2M | ||
| Q3 25 | $-5.5M | $-938.0K | ||
| Q2 25 | $-5.6M | $-503.0K | ||
| Q1 25 | $-11.4M | $-2.3M | ||
| Q4 24 | $9.6M | $1.5M | ||
| Q3 24 | $941.0K | $495.0K | ||
| Q2 24 | $-10.4M | $230.0K | ||
| Q1 24 | $-6.2M | $662.0K |
毛利率CTKBINTT
| Q4 25 | 52.9% | 45.4% | ||
| Q3 25 | 52.7% | 41.9% | ||
| Q2 25 | 52.3% | 42.6% | ||
| Q1 25 | 48.6% | 41.5% | ||
| Q4 24 | 58.5% | 39.7% | ||
| Q3 24 | 56.3% | 46.3% | ||
| Q2 24 | 54.6% | 40.6% | ||
| Q1 24 | 51.3% | 43.8% |
营业利润率CTKBINTT
| Q4 25 | -9.0% | 3.9% | ||
| Q3 25 | -17.6% | -4.5% | ||
| Q2 25 | -23.3% | -3.3% | ||
| Q1 25 | -36.1% | -10.8% | ||
| Q4 24 | 5.2% | 5.7% | ||
| Q3 24 | -8.2% | 1.6% | ||
| Q2 24 | -18.3% | 1.0% | ||
| Q1 24 | -23.9% | 1.6% |
净利率CTKBINTT
| Q4 25 | -70.9% | 3.8% | ||
| Q3 25 | -10.5% | -3.6% | ||
| Q2 25 | -12.2% | -1.8% | ||
| Q1 25 | -27.5% | -8.7% | ||
| Q4 24 | 16.8% | 4.1% | ||
| Q3 24 | 1.8% | 1.6% | ||
| Q2 24 | -22.4% | 0.7% | ||
| Q1 24 | -13.8% | 2.2% |
每股收益（稀释后）CTKBINTT
| Q4 25 | — | $0.10 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | — | $-0.04 | ||
| Q1 25 | — | $-0.19 | ||
| Q4 24 | — | $0.13 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $0.02 | ||
| Q1 24 | — | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $14.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $103.6M |
| 总资产 | $461.5M | $151.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBINTT
| Q4 25 | $90.9M | $14.2M | ||
| Q3 25 | $93.3M | $16.2M | ||
| Q2 25 | $75.5M | $19.2M | ||
| Q1 25 | $95.3M | $22.0M | ||
| Q4 24 | $98.7M | $19.8M | ||
| Q3 24 | $162.3M | $18.0M | ||
| Q2 24 | $177.9M | $20.4M | ||
| Q1 24 | $168.8M | $27.3M |
总债务CTKBINTT
| Q4 25 | — | — | ||
| Q3 25 | — | $4.9M | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $7.9M | ||
| Q3 24 | — | $9.0M | ||
| Q2 24 | — | $10.0M | ||
| Q1 24 | — | $11.0M |
股东权益CTKBINTT
| Q4 25 | $341.7M | $103.6M | ||
| Q3 25 | $378.6M | $101.9M | ||
| Q2 25 | $377.6M | $102.6M | ||
| Q1 25 | $379.6M | $99.4M | ||
| Q4 24 | $395.7M | $99.8M | ||
| Q3 24 | $385.5M | $100.4M | ||
| Q2 24 | $389.1M | $99.5M | ||
| Q1 24 | $392.6M | $99.3M |
总资产CTKBINTT
| Q4 25 | $461.5M | $151.3M | ||
| Q3 25 | $494.9M | $148.3M | ||
| Q2 25 | $493.3M | $149.7M | ||
| Q1 25 | $482.6M | $148.0M | ||
| Q4 24 | $499.5M | $152.3M | ||
| Q3 24 | $491.2M | $158.4M | ||
| Q2 24 | $483.7M | $160.6M | ||
| Q1 24 | $492.1M | $159.5M |
负债/权益比CTKBINTT
| Q4 25 | — | — | ||
| Q3 25 | — | 0.05× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | 0.10× | ||
| Q1 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $-1.0M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $-1.6M |
| 自由现金流率自由现金流/营收 | -2.9% | -4.7% |
| 资本支出强度资本支出/营收 | 1.6% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.82× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $5.7M |
8季度趋势，按日历期对齐
经营现金流CTKBINTT
| Q4 25 | $-771.0K | $-1.0M | ||
| Q3 25 | $-3.9M | $3.5M | ||
| Q2 25 | $108.0K | $-688.0K | ||
| Q1 25 | $-125.0K | $5.5M | ||
| Q4 24 | $2.0M | $2.6M | ||
| Q3 24 | $13.2M | $4.2M | ||
| Q2 24 | $6.2M | $-5.1M | ||
| Q1 24 | $4.0M | $2.1M |
自由现金流CTKBINTT
| Q4 25 | $-1.8M | $-1.6M | ||
| Q3 25 | $-4.6M | $3.1M | ||
| Q2 25 | $-1.5M | $-1.1M | ||
| Q1 25 | $-974.0K | $5.3M | ||
| Q4 24 | $1.1M | $2.4M | ||
| Q3 24 | $12.2M | $3.7M | ||
| Q2 24 | $5.2M | $-5.4M | ||
| Q1 24 | $3.4M | $1.7M |
自由现金流率CTKBINTT
| Q4 25 | -2.9% | -4.7% | ||
| Q3 25 | -8.7% | 11.8% | ||
| Q2 25 | -3.2% | -4.1% | ||
| Q1 25 | -2.3% | 19.9% | ||
| Q4 24 | 1.9% | 6.6% | ||
| Q3 24 | 23.7% | 12.4% | ||
| Q2 24 | 11.0% | -15.9% | ||
| Q1 24 | 7.6% | 5.8% |
资本支出强度CTKBINTT
| Q4 25 | 1.6% | 1.6% | ||
| Q3 25 | 1.3% | 1.6% | ||
| Q2 25 | 3.5% | 1.6% | ||
| Q1 25 | 2.0% | 0.9% | ||
| Q4 24 | 1.6% | 0.4% | ||
| Q3 24 | 2.0% | 1.7% | ||
| Q2 24 | 2.3% | 0.9% | ||
| Q1 24 | 1.3% | 1.1% |
现金转化率CTKBINTT
| Q4 25 | — | -0.82× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | 1.72× | ||
| Q3 24 | 14.05× | 8.58× | ||
| Q2 24 | — | -22.13× | ||
| Q1 24 | — | 3.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
INTT
| Environmental Technologies | $8.3M | 25% |
| Semiconductor Market | $6.9M | 21% |
| Thermal Testing Products | $6.4M | 19% |
| Service And Other Products | $4.8M | 15% |
| Oem Integrators And Distributor | $3.5M | 11% |
| Semiconductor Production Test Products | $3.0M | 9% |
